wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33414468-541113AD-E29C-4BB3-B007-54C5172319D6
Q33414468-541113AD-E29C-4BB3-B007-54C5172319D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414468-541113AD-E29C-4BB3-B007-54C5172319D6
Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.
P2860
Q33414468-541113AD-E29C-4BB3-B007-54C5172319D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414468-541113AD-E29C-4BB3-B007-54C5172319D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
24174973cf4938a7c0c84f7df72363a5bb66e8ea
P2860
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.